Used in research settings as a potent and selective inhibitor of lysine-specific demethylase 1 (LSD1), showing promise in epigenetic therapy for certain cancers. Demonstrates activity in differentiation models of acute myeloid leukemia (AML) and other hematological malignancies by reactivating silenced tumor suppressor genes. Investigated for its ability to modulate gene expression when combined with other agents like retinoic acid or hypomethylating drugs, enhancing anti-tumor effects. Also employed as a tool compound to study chromatin remodeling and cellular differentiation pathways.